Literature DB >> 21376620

Even short-time storage in physiological saline solution impairs endothelial vascular function of saphenous vein grafts.

Manuel Wilbring1, Sems Malte Tugtekin, Birgit Zatschler, Anette Ebner, Hermann Reichenspurner, Klaus Matschke, Andreas Deussen.   

Abstract

OBJECTIVES: A faultless endothelial layer is decisive for vascular function and therewith graft's patency. Functional impairment of the endothelium increases risk of graft thrombosis, intimal hyperplasia, and consecutive accelerated graft atherosclerosis. Storage solutions for intra-operatively harvested saphenous vein segments (SVS) might have significant impact on endothelial function. We investigated the impact of short-time storage in physiological saline solution (PSS) and a potassium-chloride- and N-acetylhistidine-enriched storage solution on venous endothelial function.
METHODS: Intra-operatively isolated SVSs (n=19) were stored in different storage solutions for 90 min. They were then immediately studied in tissue bath at 36°C with continuous oxygen insufflation. Following preconstriction with norepinephrine, dose-response relaxation curves of bradykinine (Brad) and sodium nitroprusside (SNP) were determined. We compared developed maximum wall tension, vessel constriction kinetics, endothelial cell- and smooth muscle cell (SMC)-dependent vasodilatory function.
RESULTS: Maximum vessel wall tension was reduced significantly in PSS-stored vessels (10.1 ± 9.8 mN mm(-1) vs 3.5 ± 3.4 mN mm(-1); p=0.0372). Endothelium-derived vasodilatory function was likewise significantly reduced after short-time storage (20.6 ± 34.4% vs 35.0 ± 27.0%; p=0.0437). SNP-mediated SMC-vasodilatory function was maintained equally well in both groups (88.2 ± 21.8% vs 83.0 ± 30.6% in PSS; p=n.s.).
CONCLUSION: Even short-time storage in PSS significantly impairs endothelial vascular function. Concerning the essential role of a faultless endothelial layer, the quite common use of PSS as a storage solution for SVSs in CABG surgery has to be discussed critically. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21376620     DOI: 10.1016/j.ejcts.2011.01.024

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  17 in total

Review 1.  Storage of saphenous vein grafts prior to coronary artery bypass grafting: is autologous whole blood more effective than saline in preserving graft function?

Authors:  Maria Tsakok; Sarah Montgomery-Taylor; Teresa Tsakok
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-06-29

2.  Preservation solution impacts physiologic function and cellular viability of human saphenous vein graft.

Authors:  Eric S Wise; Kyle M Hocking; Susan Eagle; Tarek Absi; Padmini Komalavilas; Joyce Cheung-Flynn; Colleen M Brophy
Journal:  Surgery       Date:  2015-05-21       Impact factor: 3.982

3.  CD68 expression in aortocoronary saphenous vein bypass grafts.

Authors:  Agnieszka Malinska; Bartlomiej Perek; Piotr Buczkowski; Katarzyna Kowalska; Danuta Ostalska-Nowicka; Wojciech Witkiewicz; Michal Nowicki
Journal:  Histochem Cell Biol       Date:  2012-12-30       Impact factor: 4.304

4.  DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial.

Authors:  Walid Ben Ali; Pierre Voisine; Peter Skov Olsen; Hugues Jeanmart; Nicolas Noiseux; Tracy Goeken; Vilas Satishchandran; Filippo Cademartiri; Garry Cutter; Dave Veerasingam; Craig Brown; Maximilian Y Emmert; Louis P Perrault
Journal:  Open Heart       Date:  2018-04-13

5.  Ephrin type-B receptor 4 activation reduces neointimal hyperplasia in human saphenous vein in vitro.

Authors:  Daniel J Wong; Daniel Y Lu; Clinton D Protack; Go Kuwahara; Hualong Bai; Nirvana Sadaghianloo; George Tellides; Alan Dardik
Journal:  J Vasc Surg       Date:  2014-10-24       Impact factor: 4.268

6.  Vein graft preservation solutions, patency, and outcomes after coronary artery bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.

Authors:  Ralf E Harskamp; John H Alexander; Phillip J Schulte; Colleen M Brophy; Michael J Mack; Eric D Peterson; Judson B Williams; C Michael Gibson; Robert M Califf; Nicholas T Kouchoukos; Robert A Harrington; T Bruce Ferguson; Renato D Lopes
Journal:  JAMA Surg       Date:  2014-08       Impact factor: 14.766

Review 7.  Saphenous vein grafts in contemporary coronary artery bypass graft surgery.

Authors:  Etem Caliskan; Domingos Ramos de Souza; Andreas Böning; Oliver J Liakopoulos; Yeong-Hoon Choi; John Pepper; C Michael Gibson; Louis P Perrault; Randall K Wolf; Ki-Bong Kim; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2019-08-27       Impact factor: 32.419

8.  Endothelial dysfunction of bypass graft: direct comparison of in vitro and in vivo models of ischemia-reperfusion injury.

Authors:  Gábor Veres; Péter Hegedűs; Enikő Barnucz; Raphael Zöller; Stephanie Klein; Harald Schmidt; Tamás Radovits; Sevil Korkmaz; Matthias Karck; Gábor Szabó
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

9.  Conduits for coronary bypass: vein grafts.

Authors:  Hendrick B Barner; Emily A Farkas
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-10-09

10.  The effect of distension pressure on endothelial injury and vasodilatation response in saphenous vein grafts: conversion of a bypass graft to a dead pipe.

Authors:  Selami Gurkan; Ozcan Gur; Volkan Yuksel; Ebru Tastekin; Serhat Huseyin; Demet Ozkaramanli Gur; Suat Canbaz
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.